Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, 1301 Morris Park Ave, Price Center, Room 208, Bronx, NY, USA.
Integrated Imaging Program, Albert Einstein College of Medicine, Bronx, NY, USA.
Clin Exp Metastasis. 2018 Apr;35(4):269-284. doi: 10.1007/s10585-017-9870-x. Epub 2018 Jan 6.
Tumors often overcome the cytotoxic effects of chemotherapy through either acquired or environment-mediated drug resistance. In addition, signals from the microenvironment obfuscate the beneficial effects of chemotherapy and may facilitate progression and metastatic dissemination. Seminal mediators in chemotherapy-induced metastasis appear to be a wide range of hematopoietic, mesenchymal and immune progenitor cells, originating from the bone marrow. The actual purpose of these cells is to orchestrate the repair response to the cytotoxic damage of chemotherapy. However, these repair responses are exploited by tumor cells at every step of the metastatic cascade, ranging from tumor cell invasion, intravasation and hematogenous dissemination to extravasation and effective colonization at the metastatic site. A better understanding of the mechanistic underpinnings of chemotherapy-induced metastasis will allow us to better predict which patients are more likely to exhibit pro-metastatic responses to chemotherapy and will help develop new therapeutic strategies to neutralize chemotherapy-driven prometastatic changes.
肿瘤通常通过获得性或环境介导的耐药性来克服化疗的细胞毒性作用。此外,来自微环境的信号会干扰化疗的有益效果,并可能促进进展和转移扩散。化疗诱导转移中的重要介质似乎是广泛的造血、间充质和免疫祖细胞,来源于骨髓。这些细胞的实际目的是协调对化疗细胞毒性损伤的修复反应。然而,在转移级联的每一步,包括肿瘤细胞侵袭、血管内渗和血源性播散,以及在转移部位的外渗和有效定植,肿瘤细胞都在利用这些修复反应。更好地理解化疗诱导转移的机制基础,将使我们能够更好地预测哪些患者更有可能对化疗表现出促转移反应,并有助于开发新的治疗策略来中和化疗驱动的促转移变化。